ClinicalTrials.gg
Sign In

Uterine Diseases clinical trials

The registry lists 73 studies for Uterine Diseases across more than 10 countries. 9 are recruiting or about to start. 41 of them are mainly about Uterine Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 18 narrower conditions too, such as Uterine Cervical Neoplasms: 5,099 studies, 1,361 open.

Get an email when these change. Save the Uterine Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
50
Status unknown
9
Recruiting
7
Terminated
3
Not yet recruiting
2
Withdrawn
1

Phase

Phase 4
9
Phase 2
8
Phase 3
5
Phase 1
4

Where

United States
17
Italy
11
Korea, Republic of
6
Egypt
6
Turkey
6
France
4

Who runs them

University of Palermo (4) · CHA University (2) · NiKang Therapeutics, Inc. (2) · Asan Medical Center (2) · Ain Shams University (2) · University Hospital Tuebingen (2) · Cairo University (2) · University Hospital, Clermont-Ferrand (1)

What is being tested here

Drugs under test in Uterine Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tisotumab vedotin101
Bulumtatug fuvedotin111
Naproxen001
Selinexor011
Lidocaine Topical001
Axalimogene filolisbac001
Drospirenone001
Estetrol001
Nomegestrol acetate001
Estradiol001

Coming up

1phase 3 study under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 7 Uterine Diseases studies recruiting now, 2 (29%) set no upper age limit and 5 (71%) stop at 75 or younger. 0 (0%) take children under 18. 6 (86%) are for women only and 0 (0%) for men only; 1 (14%) take healthy volunteers.

Recruiting studies that take each age, of 7
AgeWomenMen
100 (0%)0 (0%)
183 (43%)0 (0%)
306 (86%)1 (14%)
407 (100%)1 (14%)
507 (100%)1 (14%)
655 (71%)1 (14%)
754 (57%)1 (14%)
852 (29%)1 (14%)

Across all 73 studies, recruiting or not: 55% stop at 75 or younger and 38% at 65; 8% take children; 95% are for women only and 0% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Uterine Diseases studies take

Of 28 interventional studies with no phase under Uterine Diseases, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo7–24 · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.